Risk factors for Incident Trichomonas vaginalis among Women Recruited in RESPECT-2, an HIV Prevention Trial D Helms 1, D Mosure 1, T Peterman 1, C Metcalf.

Slides:



Advertisements
Similar presentations
The Connection Between STDs and HIV
Advertisements

Repeat Chlamydia trachomatis: Rate and Predictors among Males Eileen F. Dunne M.D., M.P.H. JB Chapin, C Rietmeijer, CK Kent, J Ellen, C Gaydos, N Willard,
Repeat Infections among Adolescents and Young Adults: Findings From Philadelphia STD Clinics Nicole Liddon, PhD 1 Michael Eberhart, BS 2 Jami Leichliter,
Intimate Partner Violence (IPV) and Women’s Health during Pregnancy Findings from the Rhode Island PRAMS Hanna Kim, Samara Viner-Brown, Rachel.
Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
Persistence of HPV in a cohort of female adolescents Erika Samoff, Emilia H. Koumans, Lauri E. Markowitz, Maya Sternberg, Mary K. Sawyer, David Swan, John.
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
Field Based Treatment of Chlamydia and Gonorrhea Nilmarie Guzmán,MD & Michael Sands,MD University of Florida/Jacksonville and the Duval County Health Department.
The Relationship Between Repeat Infections and Behavioral Risk Factors and Clinician Counseling: Findings from a Philadelphia STD Clinic M. Eberhart 1,
Epidemiology of Chlamydia in the United States Debra J. Mosure, Ph.D. Division of STD Prevention Centers for Disease Control and Prevention March 8, 2004.
STDs and HIV Among Youth in Nevada
Once Is Not Enough: Re-screening Sexually Transmitted Disease (STD) Clinic Patients in Six Months to Detect New STDs Once Is Not Enough: Re-screening Sexually.
Repeat Chlamydial Infections in Region III Family Planning Clinics: Implications for Screening Programs Pamela G. Nathanson, Family Planning Council, Inc.
HIV INTERVENTION FOR PROVIDERS (HIP) Principal Investigators:  Carol Dawson Rose, RN, Ph.D. and Grant Colfax, MD. Co-Investigators:  Cynthia Gomez, Ph.D.,
Curable versus incurable STDs. Objectives To describe the natural history and epidemiology of two curable STDs (i.e. syphilis and chlamydia) and two non-
Sexually Transmitted Diseases North Dakota 2001 STD Program Division of Disease Control North Dakota Department of Health.
Asthma Prevalence in the United States National Center for Environmental Health Division of Environmental Hazards and Health Effects June 2014.
Changes in Sex Networks and Repeat STDs among Male Adolescents and Young Adults Jonathan M Ellen 1, Charlotte Gaydos 1, Michelle Chung 1, Nancy Willard.
Florida Department of Health HIV/AIDS & Hepatitis Section Annual data trends as of 12/31/2012 Living (Prevalence) data as of 05/16/2012 Epidemiology of.
Distribution of Trichomonas vaginalis Among Women at High Risk for HIV Infection Barbara Van Der Pol, James Williams, Jacquelyn Murphy and the Project.
Randomized Controlled Trial of HIV Counseling with Rapid and Standard HIV Tests (RESPECT-2) Preliminary results Carol Metcalf 1, Helene Cross 2, Beth Dillon.
HIV/STD Epidemiology in Oklahoma HIV/STD Service Division of Prevention and Preparedness Oklahoma State Department of Health.
HIV & AIDS Cases in Alameda County Presentation to the CCPC August 24, 2011 Elaine Bautista & Alex Marr.
Genital Human Papillomavirus Infection: Incidence and Risk Factors in a Cohort of Female University Students R.L. Winer, Shu-Kuang Lee, J.P. Hughes, D.
Population attributable risks for low birth weight among singleton births—Colorado, Ashley Juhl, MSPH Epidemiology, Planning and Evaluation Branch.
STD’s and Health in the Latino Community- Learn the facts Elizabeth Lee-Rey, MD Co-Director Hispanic Center of Excellence/AECOM March 28, 2003.
Re-Screening of CT Positive Clients in Region X IPP, Goldenkranz S., 1 Fine D. 1 1 Center for Health Training 2010 CDC STD Prevention Meeting,
Context and Association of Meth Use and Sexual Risk Behavior David W. Purcell, JD, PhD Prevention Research Branch Division of HIV/AIDS Prevention, NCHHSTP,
Sexually Transmitted Disease (STD) Surveillance Report, 2009 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
Sexually Transmitted Infections Mysheika Williams Roberts, MD, MPH Medical Director Assistant Health Commissioner Columbus.
Sexually Transmitted Disease Epidemiology in North Dakota Chlamydia, Gonorrhea, Hepatitis C, Syphilis and HIV Lindsey VanderBusch STD/HIV/TB/Hepatitis.
Background Study Objectives Poster No. B50 Track 2  Family planning affects women’s health and lives, and depends on a variety of socio-demographic and.
Adverse Health Conditions and Health Risk Behaviors Associated with Intimate Partner Violence in US Virgin Islands Grant Support: National Center on Minority.
1 State of the State: HIV/STD in Texas Ann Robbins Texas Department of State Health Services June 2009.
STD Surveillance Network (SSuN) Cycle 2 Objectives Lori Newman & Kristen Mahle SSuN Principal Collaborators Meeting Atlanta, GA December 2, 2008.
Chlamydial Infections in the U.S. Steven J Shapiro CCID/NCSHHSTP/DSTDP/PTB Region I Infertility Prevention Project Wells Beach, Maine June 2, 2009 Disclaimer:
Quarterly HIV/AIDS Analysis for Michigan January 1, 2008 Michigan Department of Community Health HIV/STD/Viral Hepatitis and TB Epidemiology Section Division.
SSuN: MSM prevalence monitoring and HIV Testing in STD Clinics Kristen Mahle & Lori Newman SSuN Call #3 Oct 30, 2008.
Lower Hudson Valley Perinatal Network Serving Dutchess, Putnam, Rockland & Westchester Counties Presented at the Quarterly Education & Networking Conference.
Methods Data for this NIDA-funded HIV prevention trial (Project WORTH) were drawn from 337 women offenders under community supervision, who reported using.
Epidemiology of Tuberculosis in Correctional Facilities, United States, Surveillance, Epidemiology and Outbreak Investigations Branch Division.
Sexually Transmitted Disease (STD) Surveillance Report, 2013 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
Incorporating Multiple Evidence Sources for the Assessment of Breast Cancer Policies and Practices J. Jackson-Thompson, Gentry White, Missouri Cancer Registry,
BASELINE ASSESSMENT OF CHLAMYDIA REINFECTION IN REGION VIII FAMILY PLANNING CLINICS FOR Hamby, Y, JSI Research & Training Institute Donovan,
Predicting Pregnancy Risk among Women Attending an STD Clinic Judith Shlay MD, MSPH Denver Public Health September 21, 2008 CityMatCH Conference.
2007 Youth Risk Behavior Survey Results Alaska High School Survey Grades 9-12 Alaska Division of Public Health Weighted Data Sexual Behaviors.
STIs (sexually transmitted infections) in the geriatric population
Sexually Transmitted Disease (STD) Surveillance Report, 2008 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
High prevalence rate of Trichomoniasis Vaginalis in an urban HIV clinic Debbie Mohammed, DrPH, MS, MPH, AACRN Prerak Shukla, MBBS Maria Szabela, MD Jihad.
Efficacy of a “One-Shot” Computerized, Individualized Intervention to Increase Condom Use and Decrease STDs among Clinic Patients with Main Partners Diane.
Focus Area 25 Sexually Transmitted Diseases Progress Review July 21, 2004.
Quarterly HIV/AIDS Analysis for Michigan January 1, 2007 Michigan Department of Community Health HIV/STD & Other Bloodborne Infections Surveillance Section.
STDs in Racial and Ethnic Minorities Sexually Transmitted Disease Surveillance 2003 Division of STD Prevention.
STDs in Women and Infants Sexually Transmitted Disease Surveillance 2008 Division of STD Prevention.
Housing Status and HIV Risk Behaviors Among Homeless and Housed Persons with HIV in the United States The findings and conclusions in this presentation.
Trichomonas vaginalis
Herpes Simplex Virus Type 2 infection among U.S. military service members: Public Health Implications and Opportunities for HIV Prevention Christian T.
138 th American Public Health Association Annual Meeting Denver, Colorado November 8, 2010 Determinants of HIV Testing Among High School Students with.
STI/ STD Don’t Let it Happen to You By: Andrea Abrams Linda Dhennin Reshma Prasad Rachael Walker Sharon Wang.
CONCLUSIONS New Jersey’s Emergency Department HIV testing sites report higher seroprevalence than non-ED testing sites. Since University Hospital began.
Demographic and Behavioral Differences between Latino and non-Latino Patients Attending Baltimore City STD Clinics, Renee M. Gindi 1, Kathleen.
1University of Kentucky, Lexington, Kentucky
Pengjun Lu, PhD, MPH;1 Kathy Byrd, MD, MPH;2
Sexually Transmitted Disease (STD) Surveillance Report, 2008
A study of high risk African American women, 15 to 21 years of age
Martin Goldberg1, Daniel R. Newman2, TA Peterman2,
Teen Birth Rates in California, Texas, and United States, 1991–2012.
M Javanbakht, S Guerry, LV Smith, P Kerndt
Nucleic Acid Amplification Tests for the Diagnosis of Chlamydia trachomatis Rectal Infections Bachmann LH1,2, Johnson R3, Cheng H1, Markowitz L3, Papp.
MSM Attending STD Clinics HIV Testing More Frequently: Implications for HIV Prevention and Surveillance D Helms1, H Weinstock1, K Mahle1, A Shahkolahi1,2,
Presentation transcript:

Risk factors for Incident Trichomonas vaginalis among Women Recruited in RESPECT-2, an HIV Prevention Trial D Helms 1, D Mosure 1, T Peterman 1, C Metcalf 1,2, J Douglas, Jr. 1,3, CK Malotte 4, S Paul 5 1 Centers for Disease Control and Prevention, Division of STD Prevention, Atlanta, GA 2 Aurum Institute for Health Research, Johannesburg, South Africa 3 Denver Health, Denver Colorado 4 California State University, Long Beach, CA 5 New Jersey Department of Health and Senior Services, Trenton, NJ

Trichomonas vaginalis Most common non-viral STD 5 million new infections occurring in the US annually 50% of infected females are asymptomatic Associated with adverse birth outcomes: premature rupture of the membranes, pre-term delivery, and low birth weight May increase susceptibility to, or transmissibility of, HIV Treatment cures 90-95% of infections

Epidemiology of T. vaginalis Prevalence typically ranges from 5-10% in women in the general population Risk factors for prevalent trichomonas infection include: black race, history of previous STDs, sex workers, pregnancy, multiple partners, and drug use One incidence study has been conducted* One county in China In women aged >25 years Incidence rate of 1.1 per 100 person-years *Sex Trans Dis 1996;

Objective  To determine risk factors associated with prevalent and incident trichomonas infection

Methods Data from an HIV-prevention counseling trial (RESPECT-2) 3 STD clinics in Long Beach, CA; Denver, CO; and Newark, NJ; women aged years Screened for STDs (chlamydia, gonorrhea, trichomonas) at baseline, 3, 6, 9, and 12 months Wet mount or culture was used to test for trichomonas infection

Analysis Prevalent trichomonas infection  Stratified by demographic, behavioral, and clinical risk factors Incident trichomonas infection  New Infection –  Negative test at baseline and positive test at follow-up or  Positive test at least 14 days after treatment  for a baseline infection  Stratified by demographic, behavioral, and clinical risk factors Logistic regression was used to identify risk factors

Results 1507 women 1462 tested by wet mount or culture for T. vaginalis at baseline 1269 tested at least once in follow-up* *Average duration of follow-up = 364 days 190 (13%) prevalent infections 168 (13%) incident infections

New and Repeat Infections 190 positive 1462 women 62 repeat 1272 negative 108 new infections 121 (72%) asymptomatic Baseline Follow-up Total Incident Asymptomatic 168 total incident infections

Risk Factors for Prevalent and Incident Trichomonas Infection Characteristics Prevalent % (N) Incident % (N) Age (years) (359) 10.6 (303) (461) 11.1 (395) (278) 11.3 (240) (195) 16.9 (178) (169)22.9 (153) Race/Ethnicity White 5.9 (307) 4.9 (268) Hispanic 6.5 (260) 6.1 (228) Other 7.6 (170) 6.5 (154) Black 19.6 (725)21.2 (619) Education < 12 years 16.2 (413) 17.6 (358) > 12 years 14.4 (992)14.6 (856)

Risk Factors for Prevalent and Incident Trichomonas Infection Characteristics Prevalent % (N) Incident % (N) Partners Past 3 Months 0 ▬ 10.7 (224) (747) 10.1 (751) (387) 18.9 (180) > (320) 23.6 (89) Sex for drugs/money 1 Yes 26.3 (95) 40.0 (30) No 12.1 (1359) 12.0 (990) Symptoms of Trich 2 Yes 7.5 (752) 22.1 (213) No 5.5 (710) 11.5 (1056) Chlamydia 2 Yes 21.5 (181) 36.8 (38) No 11.8 (1268) 12.3 (1169) Gonorrhea 2 Yes 22.7 (97) 38.5 (26) No 12.3 (1355) 12.4 (1187) 1 Ever exchanged sex for money or drugs 2 At time of trichomonas infection or at the last study interval

Multivariate analysis Trichomonas Infection Prevalent Incident Risk Factors AOR 95% C.I. AOR 95% C.I. Age (years) ( ) 1.1 ( ) ( ) 1.3 ( ) ( ) 1.8 ( ) ( ) 2.9 ( ) Black 3.0 ( ) 3.9 ( ) >12 years of education1.6 ( ) 1.9 ( ) Sex for drugs/money ( ) 2.6 ( ) Partners past 3 months ▬ 2.4 ( ) Symptoms 2 ▬ 2.4 ( ) Chlamydia ( ) 4.1 ( ) 1 Ever exchanged sex for money or drugs 2 At time of incident trichomonas infection or at the last study interval

Limitations Results reflect women in STD clinics RESPECT-2 was not designed to evaluate risk factors associated with trichomonas infection Possible misclassification of incident infections  Due to low sensitivity of wet mount or culture  Due to drug resistant infection

Conclusions (1) Trichomonas infection is a common infection  13% of women had a prevalent infection  13% of women had an incident infection High percentage of asymptomatic incident infection Similar risk factors for prevalent and incident infection:  Older age (>35 years), Black race, concurrent chlamydial infection, and sex for drugs/money Multiple partners and symptoms of trichomonas are risk factors for incident infection

Conclusions (2) Future studies might consider additional information regarding, contraceptive method and whether the women douched Unlike other STDs (gonorrhea and chlamydia), T. vaginalis was associated with older age in women Further investigation should be done to determine if routine screening in STD clinics would be beneficial The findings and conclusions in this presentation are those of the author(s) and do not necessarily represent the views of the Centers for Disease Control and Prevention